We distribute our research widely to institutional and retail investors through various channels, including our proprietary database, website, and other platforms (such as Bloomberg, Thomson Reuters and Factset).

We are fully MiFID II compliant. Our research is paid for by our corporate clients, and we do not carry out any execution business.

Published reports can be obtained by searching our Research Library below, or directly from the relevant Company Pages.

Advanced search
Date range (dd-mm-yyyy)

Redx Pharma

£25.5m placing extends runway to end-2022

Lighthouse | 02 December 2020

Nexstim

€0.9m prototype research project signed

Lighthouse | 18 November 2020

Hutchison China MediTech

Canada Pension Plan invests $100m at $30 per ADS

Lighthouse | 17 November 2020

Scancell

Redmile funding releases the brakes

Update | 17 November 2020

Allergy Therapeutics

Innovative G309 exploratory grass trial starts

Lighthouse | 26 October 2020

Futura Medical

MED3000: FDA details the scope of confirmatory study

Lighthouse | 22 October 2020

Mereo BioPharma

H120 results and corporate review

Update | 12 October 2020

Scancell

Redmile endorses technologies with a further £30m

Lighthouse | 12 October 2020

Nexstim

Pilot studies lift off in depression and pain

Lighthouse | 25 September 2020

Allergy Therapeutics

Strong performances against strategic goals

Initiation | 23 September 2020
219 results found.